3 items3 sources1 stocks
Seeking Alpha-Nov 6, 04:25 AM
IRhythm plans Zio MCT FDA filing in 2027 while raising 2026 revenue outlook to $890M-$895M
IRhythm plans Zio MCT FDA filing in 2027 while raising 2026 revenue outlook to $890M-$895M(摘要待生成)
The Motley Fool-Nov 6, 06:08 AM
iRhythm (IRTC) Q3 2026 Earnings Call Transcript
iRhythm (IRTC) Q3 2026 Earnings Call Transcript(摘要待生成)
Investing.com-Nov 6, 09:52 AM
Canaccord raises iRhythm stock price target on strong margins
Canaccord raises iRhythm stock price target on strong margins(摘要待生成)
IRTCequity_markets